IN8bio Inc (INAB)
1.02
0.00 (0.00%)
USD |
NASDAQ |
May 21, 10:13
IN8bio Net Income (Quarterly): -8.562M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.562M |
| December 31, 2023 | -7.598M |
| September 30, 2023 | -7.169M |
| June 30, 2023 | -7.715M |
| March 31, 2023 | -7.525M |
| December 31, 2022 | -7.798M |
| September 30, 2022 | -7.399M |
| June 30, 2022 | -7.179M |
| March 31, 2022 | -6.145M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.849M |
| September 30, 2021 | -3.391M |
| June 30, 2021 | -3.05M |
| March 31, 2021 | -2.363M |
| December 31, 2020 | -2.311M |
| September 30, 2020 | -1.681M |
| June 30, 2020 | -2.874M |
| March 31, 2020 | -1.691M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.562M
Minimum
Mar 2024
-1.681M
Maximum
Sep 2020
-5.312M
Average
-6.145M
Median
Mar 2022
Net Income (Quarterly) Benchmarks
| Jaguar Health Inc | -9.226M |
| Aptevo Therapeutics Inc | -6.834M |
| NovaBay Pharmaceuticals Inc | -3.214M |
| Palatin Technologies Inc | -8.436M |
| iBio Inc | -3.172M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 8.645M |
| EPS Diluted (Quarterly) | -0.20 |
| Enterprise Value | 31.99M |
| Earnings Yield | -89.22% |